REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/30/2025
Back to search
Official data from USPTO
CVCM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CVCM
ST13
US500000088444536Class
1, 5, 42, 44
Filing
88444536
Registration
6088484
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
07/01/2025
Trademark type
Word
Nice classes
1, 5, 42, 44
Filing date
05/23/2019
Registration date
06/30/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/30/2020
Last transaction
07/01/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
94
Owner location
TÜBINGEN, DE
Examiner
TENG, SIMON
Law office
L50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
C. S. (pessoa física)
CureVac AG
Representatives
Jennifer Fraser DYKEMA GOSSETT PLLC
Technical classification
Nice Classes
Class 1Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical reagents and biomoleculesin particular biological macromolecules in the nature of nucleic acid for industrial or scientific purposes; Reagents for research purposes
Class 5
Chemical preparations for medical usefor therapeutic and prophylactic treatment of neurologicalneuromuscularneurodegenerativeinfectious and cardiovascular diseasesof autoimmune diseases and tumoursof allergiesof metabolic diseasesof heritable genetic diseasesfor therapies replacing proteins or enzymes; pharmaceutical preparationsimmunostimulantsin particular for human or veterinary medical purposes; pharmaceutical preparationsvaccinesin particular for human or veterinary medical purposes; pharmaceutical preparationsadjuvant immunostimulants; pharmaceuticals and medicaments containing biological macromoleculesin particular for human or veterinary purposes for the treatment of neurologicalneuromuscularneurodegenerative and cardiovascular diseasesfor the treatment of infectious diseasesautoimmune diseases and tumoursfor treatment of metabolic diseases and for treatment of heritable genetic diseases and for protein or enzyme replacement therapy; gene therapy productsnucleic acid macromolecules for in vivo expression for human or veterinary medical use; Dietetic substances adapted for medical usein particular substances for food supplementsdietary food supplements
Class 42
Scientific and technological servicestechnical biology consulting and scientific research servicesin particular for identifying and characterizing biological macromolecules; pre-clinical and clinical testing of macromolecules
Class 44
Medical and veterinary servicesin particular for therapeutic and preventative treatment of tumour diseasesinfectious diseasesautoimmune disorders and allergiesfor treatment of inherited genetic diseases or for protein or enzyme replacement therapyfor treatment of neurologicalneuromuscularneurodegenerative and cardiovascular diseasesfor treatment of metabolic disorders
Publications
History of USPTO decisions and trademark events.
23 publications found
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
03/08/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
06/30/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/14/2020
PUBO
PUBLISHED FOR OPPOSITION
04/14/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/25/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/06/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/05/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/05/2020
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
03/02/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
02/22/2020
GNSL
LETTER OF SUSPENSION E-MAILED
02/22/2020
CNSL
SUSPENSION LETTER WRITTEN
02/22/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/10/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/10/2020
ALIE
ASSIGNED TO LIE
02/10/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/03/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/13/2019
GNRT
NON-FINAL ACTION E-MAILED
08/13/2019
CNRT
NON-FINAL ACTION WRITTEN
08/13/2019
DOCK
ASSIGNED TO EXAMINER
08/10/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/08/2019
NWAP
NEW APPLICATION ENTERED
05/27/2019
Continuous trademark protection
Get notified about every new filing that threatens CVCM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.